Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Muscling in on rhabdomyosarcoma

Nature Medicine volume 8, pages 1200–1201 (2002)Cite this article

A poorly understood cancer of childhood has just become less mysterious. A new animal model identifies three pathways that underlie the progression to rhabdomyosarcoma (pages 1276–1280).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Genetic pathways altered in rhabdomyosarcomas.

References

  1. Enzinger, F.M. & Weiss, S.W. Soft Tissue Tumors. 3rd. edn (C.V. Mosby, St. Louis, 2000).

  2. Sharp, R. et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nature Med. 8, 1276–1280 (2002).

    Article  CAS  Google Scholar 

  3. Tonin, P.T. et al. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res. 51, 5100–5106 (1991).

    CAS  PubMed  Google Scholar 

  4. Maelandsmo, G.M. et al. Homozygous deletion frequency and expression levels of the CDKN2A gene in human sarcomas—relationship to amplification and mRNA levels. Br. J. Cancer 72, 393–398 (1995).

    Article  CAS  Google Scholar 

  5. Mulligan, L.M. et al. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA 87, 5863–5867 (1990).

    Article  CAS  Google Scholar 

  6. Merlino, G. & Helman, L.J. Rhabdomyosarcoma—working out the pathways. Oncogene 12, 1697–1705 (1996).

    Google Scholar 

  7. Ferracini, R. et al. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcoma. Oncogene 12, 1697–1705 (1996).

    CAS  PubMed  Google Scholar 

  8. Takayama, H. et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 94, 701–706 (1997).

    Article  CAS  Google Scholar 

  9. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ludwig Institute for Cancer Research Department of Medicine, Cancer Center and Center for Molecular Genetics University of California at San Diego, La Jolla, California, USA

    Webster K. Cavenee

Authors
  1. Webster K. Cavenee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cavenee, W. Muscling in on rhabdomyosarcoma. Nat Med 8, 1200–1201 (2002). https://doi.org/10.1038/nm1102-1200

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1102-1200

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing